Literature DB >> 3918174

Polymer-level synthesis of oxopyrimidine deoxynucleotides by Bacillus subtilis phage SP10: characterization of modification-defective mutants.

H Witmer, C Wiatr.   

Abstract

Bacillus subtilis phage SP10 DNA has two oxopyrimidines, thymidine 5'-monophosphate (dTMP) and its hypermodified analog (YdTMP). Published data suggest that both are synthesized by postreplicational modification of 5-hydroxymethyldeoxyuridylate (HOMedUMP) in nascent DNA by the following pathway: HOMedUMP----PPOMedUMP----dTMP (85%) or YdTMP (15%); PPOMedUMP is 5-(hydroxymethyl-O-pyrophosphoryl)deoxyuridylate, the pyrophosphoric acid ester of the C5CH2OH function of HOMedUMP. This paper describes aberrant DNAs synthesized at nonpermissive temperatures by a complementary series of heat-sensitive, modification-defective (mod) mutants. Collectively, these mutants encompass the major steps in the complete modification of nascent SP10 DNA. DNA produced by modA phage retains HOMedUMP as its sole oxopyrimidine, implying that (i) this mutant is defective in the pyrophosphorylation step and (ii) formation of PPOMedUMP is required for any further modification. Furthermore, studies with double mutants indicated that modA is epistatic for all other mod mutants, which supports the hypothesis that modA controls the earliest step in the modification pathway. Since their DNAs contain no YdTMP, modC and modD are defective in hypermodification (i.e., PPOMedUMP----YdTMP). However, dTMP occupies the entire oxopyrimidine fraction of modC DNA, whereas modD DNA has a normal dTMP content, but the now-missing YdTMP is replaced by either PPOMedUMP or a byproduct of abortive hypermodification. It is proposed that the modD mutants are defective in the catalytic aspects of hypermodification and that modC are defective in some regulatory function that promotes hypermodification at the expense of reductive modification (i.e., PPOMedUMP----dTMP). Reductive modification is defective in modB phage, as evidenced by the absence of dTMP. In contrast to the others, modB DNA has a complex oxopyrimidine content: HOMedUMP, ca. 30%; PPOMedUMP, ca. 40%; and YdTMP, ca. 30%. The expanded level of YdTMP suggests that at certain sites, reductive modification and hypermodification are competing reactions. Interestingly, the PPOMedUMP content of modB DNA seemingly reflects the maximum degree to which phage DNA can be pyrophosphorylated, since the loss of YdTMP from modBmodC and modBmodD DNAs results in a unilateral increase in HOMedUMP content.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3918174      PMCID: PMC254666     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

Review 1.  Modified bases in bacteriophage DNAs.

Authors:  R A Warren
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

2.  Inhibition of a discrete bacterial DNA polymerase by 6-(p-hydroxyphenylazo)-uracil and 6-(p-hydroxyphenylazo-)-isocytosine.

Authors:  M M Neville; N C Brown
Journal:  Nat New Biol       Date:  1972-11-15

3.  Deoxythymidine nucleotide metabolism in Bacillus subtilis W23 infected with bacteriophage SP1Oc: preliminary evidence that dTMP in SP10c DNA is synthesized by a novel, bacteriophage-specific mechanism.

Authors:  O Markewych; E Casella; M Dosmar; H Witmer
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

4.  Bacteriophage phi W-14-infected Pseudomonas acidovorans synthesizes hydroxymethyldeoxyuridine triphosphate.

Authors:  J Neuhard; K L Maltman; R A Warren
Journal:  J Virol       Date:  1980-05       Impact factor: 5.103

5.  5-[(Hydroxymethyl)-O-pyrophosphoryl]uracil, an intermediate in the biosynthesis of alpha-putrescinylthymine in deoxyribonucleic acid of bacteriophage phi W-14.

Authors:  K L Maltman; J Neuhard; R A Warren
Journal:  Biochemistry       Date:  1981-06-09       Impact factor: 3.162

6.  Selective protection of 5' ... GGCC ... 3' and 5' ... GCNGC ... 3' sequences by the hypermodified oxopyrimidine in Bacillus subtilis bacteriophage SP10 DNA.

Authors:  C L Wiatr; H J Witmer
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

7.  Production and expression of dTMP-enriched DNA of bacteriophage SP15.

Authors:  E Casella; O Markewych; M Dosmar; H Witmer
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

8.  Specificity of the bacteriophage Mu mom+ -controlled DNA modification.

Authors:  S Hattman
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

9.  Biosynthesis of 5-(4'5'-dihydroxypentyl) uracil as a nucleoside triphosphate in bacteriophage SP15-infected Bacillus subtilis.

Authors:  M S Walker; M Mandel
Journal:  J Virol       Date:  1978-02       Impact factor: 5.103

10.  SP-10 bacteriophage-specific nucleic acid and enzyme synthesis in Bacillus subtilis W23.

Authors:  O Markewych; A Boghosian; M Dosmar; D Ende; H Witmer
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

View more
  4 in total

1.  Computational identification of novel biochemical systems involved in oxidation, glycosylation and other complex modifications of bases in DNA.

Authors:  Lakshminarayan M Iyer; Dapeng Zhang; A Maxwell Burroughs; L Aravind
Journal:  Nucleic Acids Res       Date:  2013-06-28       Impact factor: 16.971

2.  CARF and WYL domains: ligand-binding regulators of prokaryotic defense systems.

Authors:  Kira S Makarova; Vivek Anantharaman; Nick V Grishin; Eugene V Koonin; L Aravind
Journal:  Front Genet       Date:  2014-04-30       Impact factor: 4.599

Review 3.  Adenine methylation in eukaryotes: Apprehending the complex evolutionary history and functional potential of an epigenetic modification.

Authors:  Lakshminarayan M Iyer; Dapeng Zhang; L Aravind
Journal:  Bioessays       Date:  2015-12-12       Impact factor: 4.345

4.  Pathways of thymidine hypermodification.

Authors:  Yan-Jiun Lee; Nan Dai; Stephanie I Müller; Chudi Guan; Mackenzie J Parker; Morgan E Fraser; Shannon E Walsh; Janani Sridar; Andrew Mulholland; Krutika Nayak; Zhiyi Sun; Yu-Cheng Lin; Donald G Comb; Katherine Marks; Reyaz Gonzalez; Daniel P Dowling; Vahe Bandarian; Lana Saleh; Ivan R Corrêa; Peter R Weigele
Journal:  Nucleic Acids Res       Date:  2022-04-08       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.